Japan Tissue Engineering Co., Ltd.

J-TEC is a bio-venture enterprise founded on the premise that J-TEC will "develop a basic tissue regeneration medical treatment based on the science of tissue engineering, which will bring a qualitative change in medical treatment practices, and thus develop into a business that will transform 21st century medical treatment itself". The business groups being developed by J-TEC include our "Regenerative Medicine Business", with the main objective of developing, manufacturing and selling tissue-engineered medical products and related products, and as such, is subject to the Pharmaceutical and Medical Device Act * and a second business group called the "R&D Support Business", which is not subject to this law. Also,we develop a third business group called the "Custom Development & Manufacturing Business" as a Contract Development and Manufacturing Organization (CDMO), and as a Contract Research Organization (CRO).

• Employees 220
• Founded 1999
• Annual Revenue $16524000